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1. Introduction 
In 1970 an acidic, lipophilic antibiotic was isolated 
from the fermented broth of Streptomyces arenae 
strain Tii 469 which was called arenaemycin [l] . 
Preliminary results on the structure and the biological 
activity of three different forms of the antibiotic 
(arenaemycin C = chlorhydrine; arenaemycin D = 
diol; arenaemycin E = epoxide) were published [2] . 
Arenaemycin C inhibits the growth of microorga- 
nisms at OS-10 pg/ml only when growing on a 
synthetic medium in the presence of a fermentable 
sugar. The inhibitory effect can be lowered or abolish- 
ed by the use of complete medium or by, e.g., 
pyruvic acid or other carbon compounds which enter 
carbohydrate catabolism ‘below’ the pyruvate kinase 
reaction. These observations suggested that 
arenaemycin terferes with a glycolytic reaction 
which is not involved in gluconeogenesis [2]. 
A recent survey (W. Keller-Schierlein, personal com- 
munication) showed by comparison of the chemical 
data [2-41 that arenaemycin E is identical with 
pentalenolactone, anantibiotic isolated from the 
fermented broth of different Streptomyces species 
in the course of screening programs for antimeta- 
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Fig.1. Structure of arenaemycin E/pentalenolactone [4]. 
bolites with antitumor activity [3,4] . The structure 
and absolute configuration was determined [4] and 
is shown in fig.1. 
The data presented here show that arenaemycin 
E/pentalenolactone is a potent and selective inhibitor 
of glyceraldehyde3-phosphate dehydrogenase 
(EC 1.2.1.12). 
2. Material and methods 
2.1. Isolation of arenaemycin E 
Arenaemycin E was isolated by acidification of the 
fermented broth of Streptomyces arenae strain Tii 
469 and adsorption of the cell-free filtrate on a XAD-2 
resin. After elution with methanol, purification was 
performed by column chromatography on silica gel in 
chloroform:methanol(7: 3) and on Sephadex LH-20 
in methanol. 
2.2. In vivo tests 
The inhibition of growth of Bacillus subtilis ATCC 
605 1 and Escherichia coli K 12 W 1485 by arenae- 
mycin E was assayed in 5 ml minimal medium cultures 
in the presence of 40 mM glucose. Growth rate was 
followed under sterile conditions in a Klett-photo- 
meter at 578 nm. 
The uptake of cu-[‘4C]methylglucopyranoside in 
E. coli cells was assayed as in [S] . 
2.3. Separation of glycolytic metabolites 
Exponentially growing cultures of E. coli were 
inhibited by 5 pg/ml (18 @Q arenaemycin E. Then 
25 PCi [U-14C]glucose was added and 30 min after 
addition of radioactive substrate ice-cold perchloric 
acid was added to 12% final cont. After removal of 
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cell debris the supernatant was neutralized with 30% 
KOH. After centrifugation the supernatant was 
chromatographed on Dowex 1X8 as in [6]. 
2.4. Enzyme assays 
For assays in crude extracts of E. coli and 
B. subtilis the cells were harvested in the middle of 
the logarithmic phase and disrupted by sonification. 
The activity of glyceraldehyde-3.phosphate dehy- 
drogenase was assayed in 0.1 M imidazole buffer 
pH 7.4, containing 250 PM freshly prepared glyceral- 
dehyde3-phosphate, 5 mM sodium arsenate and 
2.5 mM NAD. The other enzymes were assayed as in 
[7]. In inhibition experiments the assay mixture 
without substrate was incubated with arenaemycin E 
for 15 min. All enzymes and coenzymes were products 
of Boehringer, Mannheim. Silica gel, Dowex 1X8, 
200-400 mesh and XAD-2 were purchased from 
Serva, Heidelberg; Sephadex LH-20 from Pharmacia, 
Uppsala; and the radioactive compounds from 
Amersham, Braunschweig. The other chemicals were 
of analytical grade and from commercial sources. 
3. Results 
3 .l . The inhibitory effect of arenaemycin E and its 
reversibility 
Since we had isolated the epoxide of arenaemycin, 
we first repeated the in vivo experiments [ 1,2] which 
were performed with the epichlorhydrine. There was 
no difference in the inhibitory action despite lysis of 
B. subtilis after incubation with the antibiotic. Because 
the cross-feeding by metabolites of the destroyed cells 
lowered the inhibitory effect, the following experi- 
ments were all performed with E. coli as test orga- 
nism. To investigate the reversibility of growth 
inhibition, arenaemycin E-treated cells of E. coli were, 
after several washings, resuspended in minimal medium 
without the antibiotic. In fig.2 the rapid onset of 
growth as well as the completely unchanged growth 
rate clearly indicates that the effect of arenaemycin E 
is reversible. 
3.2. Effect of arenaemycin Eon the sugar uptake 
system 
The effect of the antibiotic on the uptake of 
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Fig.2. Inhibition of growth of E. coli by arenaemycin E. The 
arrow indicates the addition of 18 PM arenaemycin E. Popu- 
lation 1 (-o-) remained during the experiment in the 
medium with arenaemycin E. Population 2 (-•-) was 
harvested 60 mm after addition of the antibiotic and resus- 
pended in fresh medium. Population 3 (-¤-) is a uninhibited 
control, resuspended in fresh medium like population 2. 
glucose analogue cr-methylglucopyranoside, which is 
known to be transported by the glucose uptake 
system [8]. The concentration dependency of 
arenaemycin action on the sugar transport was deter- 
mined during a period of linear uptake of a-methyl- 
glucopyranoside (data not shown). At different con- 
centrations between 0.064 mM and 1.28 mM 
arenaemycin E showed no significant effect on the 
accumulation of labeled cu-methylglucopyranoside 
into the cells. 
3.3. Effect of arenaemycin E on the levels of glyco- 
lytic metabolites 
A separation of 14C-labeled glycolytic metabolites 
Volume 9 3, number 2 FEBSLETTERS September 1978 
G-6-P F-E-P FLIP (Trioso-P) 
I 





Fig.3. Levels of glycolytic metabolites in extracts of E. coli. 
The fiiure shows the total radioactivity/metabolite from 
inhibited (B) and uninhibited (o) cells after chromatographic 
separation. 
from arenaemycin E-treated and -untreated E. coli 
cells demonstrated that in the presence of arenaemycin 
E a remarkable increase in the level of fructose-l ,6-bis- 
phosphate and a decrease in the levels of other 
metabolites occurs (fig.3). If the incubations were 
terminated after 15 min (data not shown), the effect 
on the level of fructose-l ,6-bisphosphate was less 
striking, but the levels of glucose-6-phosphate and 
fructose-6-phosphate were elevated, too. Despite the 
instability of some glycolytic metabolites (triose 
phosphates, phosphoenolpyruvate) during chromatog- 
raphy, the increase of fructose-l ,6-bisphosphate 
indicates that arenaemycin E acts on a glycolytic 
reaction ‘below’ the phosphofructokinase reaction. 
3.4.Inhibitionofglycolytic enzymes by arenaemycin E 
In crude extracts of E. coli as well as B. subtilis the 
glycolytic enzymes ‘below’ the phosphofructokinase 
reaction were assayed in the presence of the in vivo 
minimal inhibitory concentration of arenaemycin 
(18 PM). Aldolase, enolase and pyruvate kinase were 
not affected while glyceraldehyde3-phosphate dehy- 
drogenase was totally inhibited by the antibiotic. 
Triosephosphate isomerase and phosphoglycerate 
kinase have not been assayed as in these enzymatic 
tests, glyceraldehyde3-phosphate dehydrogenase is 
an auxiliary enzyme. 
3.5. Selectivity of arenaemycin E in vitro 
A series of commercially available enzymes of the 
intermediary metabolism were assayed in the presence 
of 18 I.IM arenaemycin E. This concentration produces 
total inhibition of glyceraldehyde3-phosphate 
dehydrogenase from rabbit muscle. Alcohol dehy- 
drogenase, glucose-6-phosphate dehydrogenase, and 
hexokinase from yeast, lactate dehydrogenase from 
pig muscle, malate dehydrogenase from pig heart, 
glutamate dehydrogenase from bovine liver, gluta- 
mate-pyruvate transaminase and fructose-l ,6-bis- 
phosphatase from rabbit muscle remained completely 
unaffected by the antibiotic. Enolase and pyruvate 
kinase from rabbit muscle were only slightly (l-S% 
inhibition) affected by arenaemycin E. 
3.6 Concentration dependency of arenaemycin action 
in vitro 
The inhibitory effect of arenaemycin E was inves- 
tigated using commercially available preparations of 
glyceraldehyde-3-phosphate dehydrogenase from 
yeast and rabbit muscle. The concentration depen- 
dency of inhibition shows that the enzyme from yeast 
is less sensitive to the antibiotic compared with the 
enzyme from rabbit muscle (fig.4). In every case the 
arenaemycin concentration needed for total enzyme 
inhibition is much lower than those used in the 





Fig.4. Inhibition of glyceraldehyde-3-phosphate dehydro- 
genase by arenaemycin E. The enzymes from yeast (open 
circles) and from rabbit muscle (closed circles) were assayed. 
Enzyme concentration was 8.6 X lo-’ M. 
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4. Discussion 
The previous investigations on arenaemycin action 
in vivo [ 1,2] suggested that this antibiotic acts by 
inhibition of the glycolytic pathway. This study 
shows that arenaemycin E inhibits the enzyme 
~yceraldehyde-3-phosphate dehydrogenase from 
pro- and eucaryotic organisms. The uptake of glucose, 
the other glycolytic reactions and a variety of enzymes 
of the intermediary metabolism remained unaffected 
by the minimal inhibitory concentration of arenae- 
mycin E in vivo. At this low concentration of the 
antibiotic growth of microor~nisms i possible with 
pyruvate as sole carbon source. A possible xplana- 
tion might be a different sensitivity of glyceraldehyde- 
3-phosphate dehydrogenase to arenaemycin depending 
upon the actual substrate concentration. Preliminary 
kinetic results point in that direction. A highly reac- 
tive moiety in the molecule of arenaemycin Elpenta- 
lenolactone is the epoxide. Glyceraldehyde-3-phos- 
phate dehydrogenase i  known to react with epo- 
xides 19,101, but in the case of arenaemycin the 
reaction of the epoxide moiety with the enzymes 
seems not to be responsible for i~ibition for the 
following reasons: 
1. The inhibition of glyceraldehyde3-phosphate dehy- 
drogenase by arenaemycin E cannot be prevented 
by thiols. 
2. Arenaemyc~ E has no effect on alcohol dehydro- 
genase as described for arene’oxides [lo] , 
3. The in vivo experiments [ I,2 ] were performed with 
the epichlorhydrine and show the same inhibition 
characteristics a our experiments with the epo- 
xide. 
In general, arenaemyc~ seems to be a potent and 
selective inhibitor of glycolysis. It therefore might 
be a helpful tool in studies on energy metabolism, 
in studies on the glucose ffect of metabolic regula- 
tion, and possibly in studies with tumor cells which 
often show a high rate of glycolysis. 
Professor Hans Zihner, Lehrstuhl fur Mikrobiolo- 
gie, Universitiit Tiibingen is greatfully acknowledged 
for stimulating this work by helpful discussions and 
by making the antibiotic available. The authors are 
indebted to Dr Anton Ha~nb~~er for the cultures 
of Streptomyces arenae and for assistance in the 
isolation of arenaemycin. The work was supported 
by the Deutsche Forschungsgemeinschaft SFB 76 
and by the Fonds der Chemischen I dustrie. 
References 
[I] Lemke, J. (1971) DoctoralThesis, University of
Tiibingen. 
[2] Keller-Schierlein, W., Lemke, J., Nyfeler, R. and 
Z&her, H. (1972) Arch. Microbial. 84,301-316. 
[3] Takeuchi, S., @aura, Y. and Yonehara, H. (1969) 
Tetrahedron Lett. 32,2737-2740. 
[4] Martin, D. G., Slomp, G., Mizsak, S., Duchamp, D. J. 
and Chidester, C. G. (1970) Tetrahedron Lett. 56, 
4901-4904. 
[5] Snyder, M. A., Kaczorowski, G. J., Barnes, E. M. and 
Walsh, C. (1976) J. BacterioL 127,671-673. 
[6] Hofer, H. W. (1974) Anal. Biochem. 61,54-61. 
[7] Bergmeyer, H. U. ed (1970) Methoden der enzyma- 
t&hen Analyse, Verlag Chemie, Weinheim, BergstraOe. 
[8] Postma, P. W. and Roseman, S. (1976) Biochim. 
Biophys. Acta 457,213-257. 
[9] McCaul, S. and Byers, L. D. (1976) Biochem. Biophys. 
Res. Commun. 72,1028-1034. 
f 101 Bruise, P. Y., Wilson, S. C. and Bruice, T. C, (1978) 
Biochemistry 17,1662-1669. 
342 
